Neurotrope, Inc. Announces $15.3 million Private Placement

Existing Preferred Stock Investors Convert to Common Stock, Substantially Increasing Shareholders Equity Exercise of Strategically Designed Warrant Package Could Result in Over $100 million in Additional Funding NEWARK, N.J., Nov. 16, 2015, OTCQB, NTRP /PRNewswire/ Neurotrope, Inc. (OTCQB: NTRP) today announced that it has entered into definitive agreements to sell its securities in a private placement. The securities purchase agreement provides for the sale of units to investors for $0.60 per unit with each unit consisting of one one-hundredth share of Series B Preferred Stock convertible into one share of common stock and one of each of the following warrants: (i) Series A Warrants to purchase up to an aggregate of 25,549,868 shares of common stock with an exercise price equal to $.80 per share (such exercise price subject to full protection for dilutive issuances) for a term of five years, and contain a mandatory exercise right of the Company to force exercise of the warrant if the


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: